Detailed Narrative
Robust Q1 FY26 Financial Performance
India Pesticides Limited reported a strong Q1 FY26, with revenue reaching ₹282 crores, marking a 25.8% year-on-year and 34% quarter-on-quarter growth. This was primarily volume-led, supported by sustained demand in both domestic and international markets. EBITDA increased by 62.6% YoY to ₹52 crores, resulting in an EBITDA margin of 18.4%, an expansion of 4.17 percentage points. Net profit stood at ₹35 crores, growing 79.2% YoY, with a PAT margin of 12.3%, up 3.6 percentage points.
Strategic Capacity Expansion and Utilization
The company successfully commissioned an expanded intermediate PEDA facility, increasing its capacity from 2,000 tons to 6,000 tons per annum, with a further scale-up to 8,500 metric tons per annum expected by Q2 FY26. Additionally, formulation capacity was augmented by 3,500 MT per annum. Overall blended capacity utilization was approximately 80%, with technical capacity at 73% and formulation capacity fully utilized, demonstrating efficient asset deployment.
FY26-27 Growth Outlook and Targets
IPL has set a revenue target of ₹1,000 crores for FY26, aiming for an EBITDA margin between 18-20%. For FY27, the company envisages a revenue growth of 15-20% while maintaining EBITDA margins in the 18-20% range. Sales of PEDA and Pretilachlor are projected to reach ~₹150 crores in FY26 and ₹250-300 crores in FY27, driven by increased capacity and market demand. The company also plans to launch two new products in IPL and three in its subsidiary Shalvis next year.
Hamirpur Greenfield Project as a Long-Term Driver
A significant capital expenditure of ₹64 crores is planned for the Hamirpur site in FY26, part of the total ₹116 crores capex for the year. This greenfield project is expected to generate approximately ₹100 crores in revenue in FY26-27. Over the long term⏳, the Hamirpur site has a revenue potential of ₹1,000-1,100 crores within 3-4 years, requiring a total investment of ₹400-500 crores, which will be primarily funded through internal accruals.
Product Mix and Market Dynamics
The company experienced robust growth in its herbicide business, with Pretilachlor sales reaching ~₹55 crores in Q1 FY26, benefiting from anti-dumping duties that normalized prices. Demand for fungicides like Captan and Folpet is increasing, with Folpet seeing strong export demand. While Prosulfocarb faced some pricing pressure, process optimization helped mitigate the impact. Formulation sales were flat in Q1 due to a delayed monsoon but showed substantial growth in July, indicating a recovery.
Backward Integration and Competitive Stance
IPL's strategy emphasizes backward integration, with all major existing products, including Pretilachlor, Captan, and Folpet, being backward integrated. For new products, the company adopts a phased approach, starting with introduction and then pursuing backward integration based on market response. Management acknowledged China as a competitive challenge but asserted that IPL is well-positioned due to optimized products, competitive pricing, and the benefit of anti-dumping duties on key molecules.
Improved ROCE and Financial Prudence
The company's Return on Capital Employed (ROCE) significantly improved to 18.34% from 14%, a direct outcome of a better product mix and efficient capital allocation. Management expects interest costs to reduce in subsequent quarters of FY26, driven by the liquidation of herbicide inventory and lower working capital limits. This disciplined approach underscores the company's commitment to sustainable, profitable growth and efficient financial management.